year
sinc
australian
nobel
prize
winner
sir
frank
macfarlan
burnet
togeth
john
mccrea
identifi
three
inhibitor
serum
call
abl
inactiv
influenza
viru
know
inhibitor
fact
protein
call
lectin
mbl
compon
innat
immun
system
past
year
understand
protein
steadili
increas
result
extens
research
activ
three
main
area
bioimmunochemistri
includ
molecular
genet
b
microbiolog
c
immunodefici
work
area
initi
proceed
independ
evid
inexplic
biolog
function
clinic
defici
state
emerg
isol
character
protein
necessari
order
illumin
observ
rarf
bactericid
activ
microbiolog
area
opson
defici
report
mani
paediatr
popul
main
develop
summar
tabl
review
briefli
address
issu
relat
earli
histori
mbl
structur
function
genet
diseas
associ
final
futur
develop
includ
potenti
use
recombin
mbl
discuss
exist
mammalian
serum
lectin
first
predict
robinson
et
al
protein
first
isol
cytosol
fraction
rabbit
liver
kawasaki
et
al
subsequ
wild
et
al
abl
isol
mbl
human
rat
liver
recent
extrahepat
transcript
mbl
report
may
implic
regard
role
local
host
defenc
mbl
belong
famili
protein
call
collectin
possess
collagen
region
lectin
domain
major
human
collectin
surfact
protein
surfact
protein
possess
structur
characterist
similar
mbl
found
predominantli
lung
mucos
site
protein
structur
mbl
studi
extens
aspect
present
protein
consist
multim
ident
polypeptid
chain
kda
chain
compris
four
distinct
region
encod
differ
exon
gene
discuss
detail
later
chain
domain
crd
short
hydrophob
neck
region
configur
collagen
region
contain
triplet
region
three
polypeptid
chain
form
tripl
helix
within
collagen
region
stabil
hydrophob
interact
interchain
disulphid
bond
within
region
basic
build
block
circul
molecular
form
mbl
serum
mbl
consist
oligom
rang
dimer
hexam
crystallograph
studieselectron
micrograph
reveal
oligom
sertiform
structur
due
interrupt
collagen
region
give
rise
kinkhing
abil
protein
bind
effect
microorgan
activ
complement
appear
depend
presenc
higher
order
oligom
tetram
work
drickam
colleagu
also
ezekowitz
colleagu
provid
insight
structur
crd
crd
bind
calcium
ion
enabl
form
bond
group
specif
sugar
includ
mannos
fucos
glucos
three
crd
structur
subunit
separ
constant
distanc
cluster
structur
subunit
provid
flat
platform
permit
bind
mbl
array
repeat
sugar
group
microbi
surfac
although
bind
affin
individu
interact
rel
low
format
higher
order
oligom
provid
multipl
crd
abl
bind
simultan
high
avid
mbl
major
molecul
innat
immun
system
primarili
recogn
specif
sugar
group
surfac
microorgan
enabl
distinguish
self
also
bind
phospholipid
nucleic
acid
protein
mbl
shown
bind
promiscu
wide
rang
bacteria
virus
fungi
protozoa
select
exampl
list
tabl
neth
et
al
use
flow
cytometri
demonstr
mbl
bind
clinic
relev
bacteri
isol
immunocompromis
children
note
differ
bind
within
speci
one
isol
might
show
strong
bind
wherea
anoth
much
weaker
role
specif
structur
featur
microorgan
eg
capsul
permit
prevent
bind
mbl
explor
sever
studi
earliest
work
probabl
kawakami
et
al
rarf
complex
later
identifi
mbl
interact
salmonella
enterica
serovar
typhimurium
suggest
structur
composit
lipopolysaccharid
play
crucial
role
mbl
bind
function
mechan
enabl
microorgan
avoid
recognit
kill
mbl
includ
lipooligosaccharid
sialyat
despit
much
progress
area
mani
puzzl
remain
address
mostli
relat
exact
disposit
sugar
microbi
surfac
role
mbl
host
defenc
first
propos
ikeda
et
al
observ
protein
abl
activ
classic
pathway
complement
howev
clear
mbl
activ
novel
third
pathway
complement
often
term
mbl
pathway
fashion
illustr
figur
function
activ
reflect
fact
mbl
circul
associ
group
serin
proteas
masp
matsushita
fujita
demonstr
presenc
novel
complement
enzym
serum
thought
gener
convertas
associ
classic
pathway
activ
howev
activ
later
found
mediat
origin
enzym
known
may
activ
directli
subsequ
small
separ
synthes
fragment
term
smap
identifi
third
masp
known
function
also
describ
current
understand
suggest
bind
microorgan
autoactiv
occur
permit
cleavag
form
convertas
indistinguish
specif
convertas
found
two
activ
pathway
complement
note
mbl
pathway
also
activ
anoth
famili
protein
call
ficolin
ficolin
structur
similar
collectin
collagen
domain
link
domain
properti
humor
factor
synthes
hepatocyt
although
also
observ
bronchialalveolar
fluid
bile
contrast
found
peripher
blood
mononuclear
cell
polymorphonuclear
cell
type
ii
lung
epitheli
cell
ficolin
also
found
complex
masp
consid
differ
bind
specif
compar
mbl
miller
et
al
report
defect
phagocytosi
child
sever
recurr
infect
failur
thrive
diarrhoea
vitro
work
reveal
failur
child
plasma
opson
baker
yeast
saccharomyc
cerevisia
defect
later
detect
sera
children
recurr
unexplain
infect
chronic
diarrhoea
infanc
interestingli
studi
gener
popul
also
reveal
rel
high
frequenc
defect
studi
link
opson
defici
complement
system
demonstr
sera
defici
deposit
less
yeast
surfac
howev
common
opson
defect
found
associ
low
level
protein
refer
mbl
year
gene
mbl
clone
genet
human
mbl
studi
salmonella
montevideo
kuhlman
et
al
report
mbl
abl
interact
directli
cell
surfac
receptor
promot
opsonophagocytosi
subsequ
number
put
proteinsreceptor
propos
includ
howev
unclear
whether
mbl
act
direct
opsonin
mere
enhanc
complement
pathway
andor
phagocytosi
role
mbl
modul
inflamm
appear
complex
accordingli
mechan
action
remain
unexplain
one
possibl
explan
mbl
abl
trigger
proinflammatori
cytokin
releas
monocyt
concept
address
studi
jack
et
al
use
neisseria
meningitidi
incub
increas
concentr
mbl
ad
whole
blood
releas
tumour
necrosi
factor
interleukin
il
monocyt
enhanc
mbl
concentr
suppress
higher
concentr
clinic
studi
area
discuss
later
role
mbl
clearanc
apoptot
cell
first
propos
ogden
et
al
mbl
found
bind
directli
apoptot
cell
expos
termin
sugar
cytoskelet
protein
therebi
permit
recognit
directli
facilit
phagocytosi
macrophag
defect
clearanc
apoptot
cell
implic
pathogenesi
certain
autoimmun
condit
although
precis
role
mbl
remain
elus
exampl
stuart
et
al
report
although
mice
display
defect
apoptot
cell
clearanc
develop
autoimmun
diseas
anim
studi
mbl
implic
pathophysiolog
ischaemia
reperfus
injuri
due
abil
recogn
alter
stahl
colleagu
propos
lectin
pathway
mediat
process
certain
organ
absenc
mblmasp
pathway
activ
appear
afford
protect
diseas
model
howev
relev
find
human
health
need
establish
chang
cell
surfac
structur
oncogen
transform
appear
promot
bind
mbl
cancer
cell
protein
mediat
cytotox
effect
includ
cell
mediat
cytotox
rel
import
mechan
tumour
immunolog
present
unknown
mbl
occur
two
distinct
form
rodent
rhesu
monkey
one
form
found
human
chicken
discuss
previous
two
human
mbl
gene
like
due
gene
duplic
event
howev
pseudogen
potenti
mechan
respons
silenc
gene
debat
guo
et
al
describ
intron
splice
defect
two
stop
codon
exon
gene
recent
seyfarth
et
al
identifi
glycin
substitut
codon
gene
bear
close
resembl
found
codon
gene
substitut
also
found
higher
primat
includ
chimpanze
gorilla
distant
primat
rhesu
monkey
author
conclud
gene
select
silenc
molecular
mechan
skew
time
result
overal
downregul
mbl
level
present
human
popul
high
frequenc
variant
allel
observ
certain
popul
initi
puzzl
sinc
suggest
function
mbl
defici
may
well
advantag
similar
propos
mbl
genet
system
role
sickl
cell
gene
protect
malaria
occur
carrier
sickl
cell
haemoglobin
allel
argument
run
follow
certain
intracellular
parasit
use
opson
receptor
monocytesmacrophag
enter
host
therefor
reduct
function
host
may
reduc
probabl
parasit
support
notion
studi
patient
viscer
leishmaniasi
reveal
patient
like
high
mbl
level
uninfect
control
small
studi
ethiopian
patient
lepromat
borderlin
lepromat
leprosi
also
found
mbl
level
significantli
higher
healthi
blood
donor
altern
explan
unexpectedli
high
frequenc
low
mbl
phenotyp
individu
found
mani
tropic
region
excess
complement
activ
result
immunopatholog
mediat
host
damag
therefor
mechan
reduc
complement
activ
may
benefici
studi
explor
role
mbl
relat
acquisit
infecti
organ
suscept
natur
associ
clinic
cours
sever
clinic
practic
distinct
difficult
howev
purpos
review
highlight
exampl
infect
mbl
appear
influenc
one
two
aspect
infecti
diseas
hamva
et
al
recent
shown
role
mbl
mycoplasma
infect
studi
case
infect
patient
primari
antibodi
defici
pad
known
particularli
suscept
organ
compar
control
popul
pad
patient
mycoplasma
infect
mbl
defici
possess
exon
variant
allel
compar
control
group
studi
abl
demonstr
bind
mbl
three
strain
mycoplasma
use
flow
cytometri
propos
role
mbl
prevent
invas
diseas
sever
acut
respiratori
syndrom
sar
emerg
highli
infecti
diseas
caus
novel
coronaviru
provid
new
challeng
previous
unexpos
individu
predominantli
asia
specif
antibodi
could
detect
day
onset
symptom
make
suffer
reliant
innat
immun
mechan
earli
phase
infect
sinc
structur
viru
rapidli
establish
also
becam
clear
novel
infecti
agent
rich
sugar
known
target
mbl
hypothes
lectin
might
well
involv
defenc
infect
subsequ
studi
found
signific
differ
distribut
genotyp
patient
sar
compar
control
studi
suggest
mbl
play
role
suscept
infect
influenc
subsequ
sever
investig
ip
et
al
also
abl
demonstr
bind
mbl
viru
abil
inhibit
infect
number
studi
address
role
mbl
hepat
b
hepat
c
infect
yuen
et
al
investig
chronic
carrier
hepat
b
hepat
c
china
b
variant
allel
found
commonli
patient
symptomat
hepat
b
cirrhosi
spontan
bacteri
periton
also
note
mbl
level
lower
patient
cohort
chronic
infect
screen
mbl
mutat
patient
suggest
order
enabl
identif
increas
risk
complic
may
benefit
prophylact
antibiot
treatment
chong
et
al
also
report
mbl
genotyp
correl
low
protein
level
associ
occurr
cirrhosi
also
hepatocellular
carcinoma
hepat
b
carrier
also
demonstr
mbl
abl
bind
hepat
b
surfac
antigen
year
thio
et
al
publish
result
nest
studi
patient
either
natur
recov
hepat
b
n
persist
infect
n
found
mbl
genotyp
correl
high
serum
level
associ
recoveri
infect
wherea
correl
lower
level
associ
persist
viru
note
approxim
half
subject
also
infect
human
immunodefici
viru
hiv
author
conclud
influenc
result
obtain
matsushita
et
al
investig
influenc
mbl
mutat
hepat
c
infect
found
suffer
homozyg
b
variant
allel
less
like
respond
interferon
treatment
work
would
warrant
order
defin
role
mbl
pathogenesi
hepat
infect
secondari
immunodefici
due
diseas
treatment
provid
interest
patient
popul
within
studi
role
mbl
one
group
compris
receiv
chemotherapi
malign
patient
render
neutropen
treatment
underli
diseas
process
subsequ
increas
risk
infecti
complic
two
studi
publish
report
effect
mbl
defici
patient
neth
et
al
studi
children
measur
mbl
level
genotyp
children
possess
mbl
variant
allel
spent
twice
mani
day
hospit
febril
neutropenia
first
month
treatment
compar
individu
studi
peterslund
et
al
follow
adult
undergo
chemotherapi
variou
haematolog
malign
found
develop
signific
infect
bacteraemia
pneumonia
period
significantli
lower
level
mbl
compar
without
signific
infect
subsequ
studi
shown
differ
result
draw
comparison
inher
difficult
patient
highli
heterogen
popul
differ
underli
diseas
process
undergo
treatment
regimen
differ
intens
result
variou
degre
immunosuppress
one
contrast
studi
bergmann
et
al
follow
adult
undergo
therapi
acut
myeloid
leukaemia
involv
intens
highli
myelosuppress
treatment
found
effect
mbl
defici
frequenc
sever
durat
fever
suggest
natur
treatment
overwhelm
potenti
influenc
mbl
clinic
studi
patient
requir
order
delin
exact
role
mbl
mbl
mous
model
use
explor
clinic
conundrum
shi
et
al
demonstr
mbl
null
mice
highli
suscept
intraven
inocul
staphylococcu
aureu
die
within
h
compar
surviv
mbl
mice
howev
mice
inocul
via
intraperiton
rout
render
neutropen
use
cyclophosphamid
neutropen
mbl
null
mice
found
higher
accumul
bacteria
blood
organ
compar
neutropen
mice
day
neutropen
mice
clear
blood
neutropen
mbl
null
mice
persist
bacteraemia
author
abl
revers
phenotyp
treat
mbl
null
mice
recombin
mbl
date
nearli
million
human
infect
hiv
clinic
consequ
viral
exposur
variabl
individu
repeatedli
expos
viru
remain
free
infect
other
infect
remain
free
clinic
diseas
numer
viral
host
factor
determin
fate
individu
expos
hiv
data
indic
mbl
influenc
suscept
sever
hiv
infect
like
target
hiv
bind
heavili
glycosyl
glycoprotein
mbl
readili
demonstr
bind
purifi
capac
mbl
neutral
primari
hiv
isol
less
convinc
recent
data
indic
mbl
opson
hiv
induc
neutral
level
normal
present
serum
howev
bind
opson
hiv
mbl
may
alter
viru
traffick
viral
antigen
present
hiv
infect
mbl
may
influenc
uptak
dendrit
cell
dc
express
cell
surfac
lectin
call
intracellular
adhes
molecul
shown
mediat
type
infect
call
tran
dc
bind
hiv
effici
transfer
viru
cell
preincub
hiv
strain
mbl
prevent
cell
indic
least
vitro
mbl
may
inhibit
uptak
spread
hiv
whatev
mechan
mbl
interact
hiv
number
clinic
studi
suggest
defici
mbl
risk
factor
acquir
hiv
infect
mbl
defici
appear
increas
acquisit
hiv
infect
eightfold
also
increas
risk
vertic
transmiss
infect
mother
offspr
howev
find
replic
popul
studi
fail
demonstr
role
mbl
hiv
infect
even
less
clariti
regard
role
mbl
hiv
diseas
progress
gar
et
al
demonstr
men
mbl
variant
allel
shorter
surviv
time
follow
onset
acquir
immun
defici
syndrom
aid
patient
mbl
allel
howev
cohort
homosexu
men
variant
mbl
allel
insignific
effect
surviv
follow
diagnosi
aid
latter
studi
appear
protect
effect
mbl
variant
allel
delay
develop
aid
time
hiv
seroconvers
patient
mbl
variant
allel
lower
count
time
develop
aid
indic
mbl
defici
may
influenc
onset
aid
given
count
furthermor
mbl
mutat
appear
protect
develop
kaposi
sarcoma
find
difficult
explain
anoth
studi
prohaszka
et
al
found
mbl
level
lower
asymptomat
individu
compar
control
howev
protect
effect
mbl
lost
patient
aid
diagnosi
patient
high
mbl
level
significantli
lower
number
cell
possibl
explan
enhanc
proinflammatori
cytokin
product
advanc
hiv
diseas
act
increas
mbl
synthesi
elev
level
patient
diseas
inde
recent
studi
shown
vitro
mbl
enhanc
proinflammatori
cytokin
product
viral
replic
light
studi
indic
role
mbl
inflammatori
modul
tempt
suggest
circumst
mbl
may
act
promot
inflammatori
cell
activ
therebi
acceler
rate
deplet
studi
assess
impact
mbl
context
effect
antivir
therapi
howev
one
studi
attempt
relat
mbl
statu
ltnp
mbl
level
consist
genotyp
six
ltnp
studi
amoroso
colleagu
also
suggest
effect
studi
show
children
rapidli
progress
diseas
like
mbl
variant
allel
codon
slower
progressor
cystic
fibrosi
provid
exampl
clinic
condit
mbl
appear
exert
role
infect
suscept
gene
inflammatori
modul
gar
et
al
first
group
report
patient
mbl
variant
allel
significantli
impair
lung
function
decreas
life
expect
comparison
individu
effect
mbl
defici
sever
lung
diseas
appar
patient
chronic
pseudomona
aeruginosa
infect
also
found
burkholderia
cepacia
infect
common
patient
mbl
defici
davi
et
al
report
effect
mbl
seen
adult
homozyg
mbl
mutat
patient
significantli
reduc
lung
function
frequent
hospit
admiss
rais
system
inflammatori
marker
howev
evid
increas
suscept
burkholderia
cepacia
pseudomona
aeruginosa
whether
mbl
effect
earli
colon
burkholderia
cepacia
pseudomona
aeruginosa
subsequ
secondari
viral
infect
whether
anti
inflammatori
effect
subsequ
lung
damag
remain
unclear
clinic
studi
critic
ill
patient
requir
intens
care
manag
shown
individu
mbl
defici
like
develop
system
inflammatori
respons
syndrom
sir
figur
progress
septic
shock
death
find
may
well
relat
proinflammatori
cytokin
respons
also
note
chronic
inflamm
increasingli
accept
risk
factor
myocardi
infarct
mi
recent
studi
saevarsdottir
et
al
found
patient
high
mbl
level
decreas
likelihood
suffer
mi
suggest
potenti
role
mbl
modul
inflammatori
respons
compon
complement
system
similar
also
player
infecti
inflammatori
process
structur
function
mbl
prompt
studi
explor
possibl
role
autoimmun
condit
system
lupu
erythematosu
sle
focu
number
mbl
genotyp
studi
result
somewhat
inconsist
nevertheless
recent
review
studi
area
found
mbl
variant
allel
inde
sle
risk
factor
infecti
diseas
evid
risk
patholog
increas
anoth
immun
defect
exampl
cohort
spanish
patient
odd
ratio
develop
sle
individu
mbl
defici
increas
also
partial
defici
studi
patient
sle
report
mbl
defici
also
influenc
risk
develop
certain
complic
includ
arteri
thrombos
respiratori
tract
infect
role
mbl
pathogenesi
rheumatoid
arthriti
also
suggest
malhotra
et
al
report
chang
igg
glycosyl
secondari
underli
diseas
result
complement
activ
complement
activ
contribut
chronic
inflamm
synovi
membran
howev
graudal
et
al
found
patient
lower
mbl
level
experienc
earlier
sever
symptom
rapid
joint
destruct
visual
radiolog
mbl
replac
first
attempt
without
knowledg
defici
fresh
frozen
plasma
given
patient
found
correct
opson
defect
sinc
mbl
safe
given
mani
patient
result
normal
immunosorb
assay
detect
mbl
opson
activ
phase
studi
show
protein
rang
h
develop
recombin
mbl
also
phase
trial
stage
develop
provid
excit
prospect
futur
explor
therapeut
potenti
mbl
exactli
would
benefit
replac
therapi
debat
import
target
patient
group
vital
success
discoveri
compon
lectin
pathway
includ
ficolin
masp
indic
limb
immun
system
complex
extend
beyond
mbl
alon
knowledg
enabl
us
question
impact
molecul
either
isol
combin
function
assess
lectin
pathway
may
far
accur
clinic
relev
measur
mbl
level
andor
genotyp
alon
number
differ
assay
report
assess
activ
differ
stage
function
pathway
therefor
result
must
interpret
accordingli
impact
defici
variou
adjunct
compon
also
subject
much
current
research
et
al
report
first
identifi
case
defici
function
analysi
abil
mbl
activ
lectin
pathway
estim
deposit
mannan
surfac
perform
group
patient
suspect
immunodefici
one
patient
found
defici
pathway
activ
despit
suffici
mbl
found
plasma
genet
analysi
indic
patient
homozyg
point
mutat
exon
gene
clinic
patient
suffer
recurr
infect
autoimmun
symptom
subsequ
frequenc
mutat
assess
small
number
popul
valu
rang
discuss
previous
contribut
pathway
remain
unexplain
role
ficolin
begin
address
clinic
studi
like
mbl
absolut
level
defici
yet
defin
atkinson
et
al
studi
children
recurr
respiratori
tract
infect
measur
level
associ
mbl
defici
patient
cohort
alreadi
report
studi
low
level
common
patient
control
common
patient
atop
disord
suggest
role
protect
microorgan
complic
allerg
diseas
polymorph
ficolin
identifi
although
clinic
signific
yet
unknown
mbl
ancient
molecul
probabl
subject
larg
number
evolutionari
pressur
last
year
human
evolut
associ
major
chang
hominid
move
essenti
nomad
lifestyl
increasingli
crowd
live
arrang
larg
settl
commun
associ
chang
spectrum
common
infecti
diseas
would
also
chang
recent
introduct
antibiot
emerg
novel
infect
increas
use
immunosuppress
therapi
provid
new
challeng
innat
host
defenc
system
despit
chang
evolutionari
pressur
mbl
gene
polymorph
persist
high
frequenc
suggest
offer
potenti
advantag
host
thu
exist
balanc
certain
individu
benefit
express
high
level
protein
wherea
other
live
differ
environ
eg
tropic
may
benefit
reduc
level
circul
mbl
figur
mbl
statu
may
also
either
advantag
disadvantag
consid
viewpoint
sever
particular
ill
thu
known
higher
level
mbl
better
abl
modul
inflamm
probabl
effect
cytokin
respons
contrast
defici
mbl
appear
risk
sepsi
sir
reason
believ
analys
relev
mbl
extend
beyond
role
infecti
diseas
includ
clinic
area
autoimmun
inflammatori
disord
